# HCW Biologics Inc.: Form 8-K, filed Sep 5, 2025

- Company: [HCW Biologics Inc.](/companies/hcwb.md) (CIK 1828673)
- Form: 8-K
- Filed: 2025-09-05
- Accepted by EDGAR: Sep 5, 2025, 20:39 ET
- Period: 2025-09-02
- Accession: 0000950170-25-113265
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1828673/000095017025113265/hcwb-20250902.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1828673/000095017025113265/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1828673/000095017025113265/hcwb-20250902.htm

Filed Sep 5, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-113265. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.